Hemoglobin Recovery: Duration of Hemoglobin Decrease After the Initial Anti-D Treatment
All Patients (N = 253) . | Complete Recovery (N = 133) . | Second Treatment Before Recovery (N = 65) . | Last Follow-Up Visit (N = 55) . | Recovery . |
---|---|---|---|---|
. | . | . | . | % (N)5-151 . |
Day 7 | 725-150 | 23 | 28 | 28% (72/253) |
Day 14 | 24 | 17 | 18 | 47% (96/202) |
Day 21 | 13 | 12 | — | 65% (109/167) |
Day 28 | 14 | 13 | — | 79% (123/155) |
Day 42 | 10 | — | 9 | 93% (133/142) |
All Patients (N = 253) . | Complete Recovery (N = 133) . | Second Treatment Before Recovery (N = 65) . | Last Follow-Up Visit (N = 55) . | Recovery . |
---|---|---|---|---|
. | . | . | . | % (N)5-151 . |
Day 7 | 725-150 | 23 | 28 | 28% (72/253) |
Day 14 | 24 | 17 | 18 | 47% (96/202) |
Day 21 | 13 | 12 | — | 65% (109/167) |
Day 28 | 14 | 13 | — | 79% (123/155) |
Day 42 | 10 | — | 9 | 93% (133/142) |
Decrease was defined as a decrease greater than 0.2 g/dL from the pretreatment hemoglobin value. Recovery was defined as a return to the pretreatment hemoglobin value ±0.2 g/dL.
A total of 72 patients had no hemoglobin decrease 7 days after the anti-D treatment.
Patients with complete Hb recovery at a given day/evaluable patients at the same day (subtracting the ones who received a second infusion or were lost to follow-up).